Coenzyme Q10 Phase III Trial in Gulf War Illness

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

October 7, 2020

Study Completion Date

December 31, 2020

Conditions
Gulf War IllnessChronic FatigueUbiquinolCoenzyme Q10
Interventions
DRUG

Ubiquinol

Take oral tablets as directed (2x200 mg for 2 months; 1x200 mg for 4 months) with food each morning- upon waking

DRUG

Placebo

Take oral tablets as directed (2x200 mg for 2 months; 1x200 mg for 4 months) with food each morning- upon waking

Trial Locations (4)

10468

James J. Peters VA Medical Center, Bronx, NY, The Bronx

33125

Miami VA Healthcare System, Miami, FL, Miami

55417

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis

02130

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02865460 - Coenzyme Q10 Phase III Trial in Gulf War Illness | Biotech Hunter | Biotech Hunter